Files
statdx/docs_md/articles/autoimmune-encephalitis_6eb3d5d6-7f6a-4367-a792-b5d4b19675da.md
Ross 1e36a4957c .
2025-10-20 08:40:33 +01:00

46 KiB
Raw Permalink Blame History

title, docid, authors, breadcrumbs, category, documentVersionId, imageCount, lastUpdated, pageDescription, pageKeywords, pageTitle, enhancedTitle, type, references, breadcrumbs
title docid authors breadcrumbs category documentVersionId imageCount lastUpdated pageDescription pageKeywords pageTitle enhancedTitle type references breadcrumbs
Autoimmune Encephalitis 6eb3d5d6-7f6a-4367-a792-b5d4b19675da
key value
8d5254e9-8dda-478b-8f08-bdee97a32c79 Karen L. Salzman, MD, FACR
name slug treeNodeId
Brain brain 6d8829f1-14d7-45af-8675-255189aa526a
name slug treeNodeId
Diagnosis diagnosis 51c00394-446e-4a38-94af-d3b1d14d34e8
name slug treeNodeId
Pathology-Based Diagnoses pathology-based-diagnoses d9d3a8ed-f21b-4831-8c77-591a3500ef77
name slug treeNodeId
Infectious, Inflammatory, and Demyelinating Disease infectious-inflammatory-and-demyel- 7210f860-fe5f-4a2d-81cc-4fe06c769607
name slug treeNodeId
Inflammatory and Demyelinating Disease inflammatory-and-demyelinating-dis- 62ab4dc3-dbf6-45a9-8532-f0e962aa62dc
name slug treeNodeId
Autoimmune Encephalitis autoimmune-encephalitis null
Brain cc8c3891-88b7-44bb-9e2a-3a321d092f4c 22 08/05/20 Autoimmune Encephalitis Brain, Diagnosis, Pathology-Based Diagnoses, Infectious, Inflammatory, and Demyelinating Disease, Inflammatory and Demyelinating Disease, Autoimmune Encephalitis Autoimmune Encephalitis | STATdx Autoimmune Encephalitis DX true
Brain
Diagnosis
Pathology-Based Diagnoses
Infectious, Inflammatory, and Demyelinating Disease
Inflammatory and Demyelinating Disease
Autoimmune Encephalitis

title: "Autoimmune Encephalitis" docid: "6eb3d5d6-7f6a-4367-a792-b5d4b19675da" authors:

  • key: "8d5254e9-8dda-478b-8f08-bdee97a32c79" value: "Karen L. Salzman, MD, FACR" breadcrumbs:
  • name: "Brain" slug: "brain" treeNodeId: "6d8829f1-14d7-45af-8675-255189aa526a"
  • name: "Diagnosis" slug: "diagnosis" treeNodeId: "51c00394-446e-4a38-94af-d3b1d14d34e8"
  • name: "Pathology-Based Diagnoses" slug: "pathology-based-diagnoses" treeNodeId: "d9d3a8ed-f21b-4831-8c77-591a3500ef77"
  • name: "Infectious, Inflammatory, and Demyelinating Disease" slug: "infectious-inflammatory-and-demyel-" treeNodeId: "7210f860-fe5f-4a2d-81cc-4fe06c769607"
  • name: "Inflammatory and Demyelinating Disease" slug: "inflammatory-and-demyelinating-dis-" treeNodeId: "62ab4dc3-dbf6-45a9-8532-f0e962aa62dc"
  • name: "Autoimmune Encephalitis" slug: "autoimmune-encephalitis" treeNodeId: null category: "Brain" documentVersionId: "cc8c3891-88b7-44bb-9e2a-3a321d092f4c" imageCount: 22 lastUpdated: "08/05/20" pageDescription: "Autoimmune Encephalitis" pageKeywords: "Brain, Diagnosis, Pathology-Based Diagnoses, Infectious, Inflammatory, and Demyelinating Disease, Inflammatory and Demyelinating Disease, Autoimmune Encephalitis" pageTitle: "Autoimmune Encephalitis | STATdx" enhancedTitle: "Autoimmune Encephalitis" type: "DX" references: true breadcrumbs:
  • "Brain"
  • "Diagnosis"
  • "Pathology-Based Diagnoses"
  • "Infectious, Inflammatory, and Demyelinating Disease"
  • "Inflammatory and Demyelinating Disease"
  • "Autoimmune Encephalitis"

KEY FACTS

  • Terminology

    • Autoimmune encephalitis (AE): Immune-mediated disease with antibody-mediated inflammation of brain - May be immune mediated or paraneoplastic
    • Paraneoplastic: Remote neurologic effects of cancer, associated with extra-CNS tumors - Most common tumor: Small cell lung carcinoma
    • Limbic encephalitis (LE) is most common clinical paraneoplastic syndrome
  • Imaging

    • AE: T2/FLAIR hyperintensities in cortex/subcortical white matter, basal ganglia (BG), thalami, brainstem
    • AE: May have no associated imaging findings
    • LE: Hyperintensity in mesial temporal lobes/limbic system - Mimics herpes encephalitis but subacute/chronic
    • Paraneoplastic cerebellar degeneration (PCD): Cerebellar atrophy
    • Brainstem encephalitis: T2 hyperintensity in midbrain, pons, cerebellar peduncles, BG
  • Top Differential Diagnoses

    • AE: Viral encephalitis, ADEM, vasculitis
    • LE: Herpes encephalitis, diffuse astrocytoma, status epilepticus, gliomatosis cerebri imaging pattern
  • Clinical Issues

    • AE: 2 distinct groups (group I and group II) have overlapping clinical and imaging features
    • Group I (intracellular) or group II (cell surface) antigens
    • < 1% of patients with systemic cancers develop paraneoplastic syndrome
    • LE: Memory loss, cognitive dysfunction, dementia, psychological features, seizures
    • PCD: Ataxia, incoordination, dysarthria, nystagmus
    • Brainstem encephalitis: Brainstem dysfunction
    • Treatment of primary tumor may improve symptoms
    • AE treated with immunosuppressive therapy
    • AE may occur as complication of cancer treatment (immune checkpoint inhibitors)

TERMINOLOGY

  • Synonyms

    • Paraneoplastic syndromes (PS), paraneoplastic disease
  • Definitions

    • Autoimmune encephalitis (AE): Immune-mediated disease with antibody-mediated inflammation of brain - Includes autoimmune and paraneoplastic encephalitis
    • Paraneoplastic: Remote neurologic effects of cancer, associated with extra-CNS tumors - Most common tumor: Small cell lung carcinoma
    • Limbic encephalitis (LE) is most common clinical paraneoplastic syndrome - Only PS with clearly defined imaging features

IMAGING

  • General Features

    • Best diagnostic clue

      - AE: Hyperintensity in mesial temporal lobes, limbic system
              - Often mimics herpes encephalitis but has different clinical course (subacute vs. chronic)
      - Initial study normal in 20-40%
      - Most PS do not have associated imaging findings
      
    • Location

      - AE: Limbic structures, deep gray nuclei, brainstem, cortex and subcortical white matter (WM)
      - LE: Hippocampus, amygdala, cingulate gyrus, pyriform cortex, subfrontal cortex, insula
      
  • CT Findings

    • NECT: Initial CT scan normal in > 95% - Rare: Low density within mesial temporal lobes
    • CECT: Usually no visible enhancement
  • MR Findings

    • T1WI

      - AE: Hypointensity in cortex, WM, deep gray, or brainstem
      - LE: Hypointensity in mesial temporal lobes (hippocampus, amygdala), insula, cingulate gyrus, subfrontal cortex, inferior frontal WM
      - May see minimal mass effect
      - May see atrophy in chronic cases
      - No hemorrhage
      
    • DWI

      - Diffusion restriction rare
      
    • T2WI: Hyperintensity in mesial temporal lobes &/or cortex, WM, deep gray, or brainstem - May see minimal mass effect

    • FLAIR: Hyperintensity

    • T2* GRE: No hemorrhage - If blood products seen, consider herpes encephalitis

    • T1WI C+: Patchy enhancement may be seen

    • Brainstem encephalitis: T2 hyperintensity in midbrain, pons, cerebellar peduncles, basal ganglia

    • Paraneoplastic cerebellar degeneration (PCD): Cerebellar atrophy

  • Nuclear Medicine Findings

    • FDG PET: Increased glucose metabolism in medial temporal lobes in LE patients
  • Imaging Recommendations

    • Best imaging tool

      - MR is most sensitive
      
    • Protocol advice

      - Contrast-enhanced MR with coronal T2 or FLAIR
      - Consider repeat MR if initial scan normal with high clinical suspicion
      

DIFFERENTIAL DIAGNOSIS

  • Herpes Encephalitis

    • T2 hyperintensity in temporal lobes, limbic system
    • Mass effect common; restricted DWI common
    • Rapid onset, febrile illness
    • HSV titers (CSF, serum) may be negative early
    • Late acute/subacute may hemorrhage
    • May be indistinguishable from LE
  • Diffuse Astrocytoma (WHO Grade 2)

    • Unilateral T2-hyperintense mass
    • May involve medial temporal lobe
    • No enhancement typical
  • Status Epilepticus

    • Seizures related to abnormal T2/FLAIR of mesial temporal lobes
    • Cortical enhancement with DWI is typical
    • Clinical history of seizures
    • Follow-up imaging may be necessary
  • Gliomatosis Cerebri Imaging Pattern

    • Diffuse process; no predilection for limbic system
    • T2 hyperintensity in multiple contiguous lobes
    • Enlarges affected area
  • Vasculitis

    • Multiple T2/FLAIR hyperintensities
    • Blood products common
    • Small infarcts common
  • Acute Disseminated Encephalomyelitis

    • T2/FLAIR hyperintensities in WM and deep gray nuclei
    • Enhancement typical
    • Often 1-2 weeks following infection/vaccination
  • Parenchymal Metastases

    • Typically multifocal, enhancing lesions
    • Primary tumor often known
    • No predilection for limbic system

PATHOLOGY

  • General Features

    • Etiology

      - AE may be characterized as either **group I**or **group II** according to location of their neuronal antigens
              - **Group I**antibodies targeting **intracellular antigens**
              - **Group II**antibodies targeting **antigens on cell surface**:1, 2, 6, 7, 9, 27
              - Distinction clinically relevant: Implications for treatment response, association with underlying malignancy, and prognosis
      - **Group I**antibodies are more closely associated with underlying malignancy
              - Immune mediated by **autoantibodies** or cytotoxic T cell-related mechanisms
      - 60% of patients have circulating serum **autoantibodies**
              - **Anti-Hu** (75% small cell lung cancer): LE pattern
              - **Anti-Ma/Ta** (testicular germ cell tumors > > lung cancer > breast cancer): LE, brainstem encephalitis
              - **Anti-Yo** (breast and ovarian): PCD pattern
              - **Anti-Tr** (Hodgkin disease): PCD pattern
              - **Anti-Ri**(lung, breast, ovarian): Opsoclonus myoclonus, brainstem encephalitis
              - **Anti-CV2**(small-cell lung cancer, malignant thymoma): T2/FLAIR-hyperintense lesions in striatum
              - **Anti-glutamic acid decarboxylase (GAD65)**(not typically associated with malignancy): LE pattern
                        - Stiff man syndrome, cerebellar ataxia, seizures
      - Reversible extralimbic paraneoplastic encephalopathy
              - Associated with breast cancer and lung cancer
              - Reversible when primary tumors controlled
      - **Group II**cell surface antigens
              - **Voltage-gated potassium channels (VGKC)** and N-methyl-D-aspartate receptor (**NMDAR**)
                        - Appear to be antibody mediated and respond better to immunotherapy (90%)
                        - Associated with other tumors (thymoma, teratoma, Hodgkin lymphoma)
                        - Patients may present with LE; more frequently manifest severe psychiatric symptoms, seizures, dyskinesias, autonomic instability, or hypoventilation
              - Antibody to α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (**AMPAr**)
                        - Associated with LE pattern, T2 hyperintensities in hippocampus
                        - May occur with other antibodies
                        - Often associated with lung, breast, or thymic tumors
              - γ aminobutyric acid encephalitis (**GABAr**)
                        - LE pattern ± other MR findings, seizures
      
  • Staging, Grading, & Classification

    • 2 distinct groups (group I and group II) have overlapping clinical and imaging features
    • PSs divided into disorders of CNS, peripheral NS (PNS), CNS/PNS, neuromuscular junction - CNS: PCD, opsoclonus myoclonus, retinopathy - PNS: Sensory-motor neuropathy, autonomic neuropathy - Both CNS/PNS: Encephalomyelitis (LE, brainstem encephalitis, myelitis, motor neuron disease) - Neuromuscular junction: Lambert-Eaton myasthenic syndrome
    • LE is most common AE (paraneoplastic, group I) - Nonparaneoplastic LE reported
    • PCD is 2nd most common PS
    • Multiple PSs may occur in same patient
    • NMDAR and VGKC encephalitis are most common group II subtypes of AE
  • Gross Pathologic & Surgical Features

    • AE: Ill-defined softening, discoloration of gray matter - LE: Hippocampus, cingulate gyrus, pyriform cortex, frontal orbital surface of temporal lobe, insula, amygdala; typically bilateral
    • PCD: Cerebellar atrophy, gyral thinning
    • Brainstem encephalitis: Brainstem softening
  • Microscopic Features

    • AE: Neuronal loss, reactive gliosis, perivascular infiltration of lymphocytes, microglial nodules - No neoplasm and no viral inclusions
    • PCD: Purkinje cell loss, microglial proliferation, Bergmann glia hyperplasia, decrease in granule cells
    • Brainstem encephalitis: Perivascular inflammatory infiltrates, glial nodules, neuronophagia

CLINICAL ISSUES

  • Presentation

    • Most common signs/symptoms

      - AE: Memory loss, cognitive dysfunction, dementia, psychological features (anxiety, depression, hallucinations), seizures; subacute presentation
      - PCD: Ataxia, incoordination, dysarthria, nystagmus
              - In patients > 50 years, cerebellar degeneration is paraneoplastic in 50% of cases, often precedes remote malignancy
      - Brainstem encephalitis: Brainstem dysfunction including cranial nerve palsies, visual changes
      - PSs represent spectrum of neurologic manifestations
      - In patients with known primary tumor, must exclude other complications
              - Metastases, infection, metabolic disorder, chemotherapy effects
      
    • Clinical profile

      - Up to 60% of LE patients have no known primary tumor at presentation, many have no tumor found at work-up
      - Identification of antineuronal antibodies in serum or cerebrospinal fluid (CSF) facilitates diagnosis of PS and primary cancer
      - AE may occur as complication of cancer treatment (immune checkpoint inhibitors)
      - Primary neoplasms
              - LE
                        - Most common: Small cell lung carcinoma
                        - Other: Gastrointestinal, genitourinary (ovary > renal > uterus), lymphoma, breast, testicular, thymus, neuroblastoma (pediatric)
                        - 90% have positive CSF (pleocytosis, increased protein, oligoclonal bands)
                        - EEG reveals involvement of temporal lobes
              - PCD
                        - Genitourinary (ovary), breast, lung, lymphoma
              - Opsoclonus myoclonus
                        - Neuroblastoma, lung cancer
              - Lambert-Eaton myasthenic syndrome
                        - Small cell lung cancer
      
  • Demographics

    • Sex

      - No sex predominance
      
    • Age: Occurs at all ages, most commonly adults

    • Epidemiology: < 1% of patients with systemic cancers develop paraneoplastic syndrome

  • Natural History & Prognosis

    • AE has variable prognosis
    • Prognosis of PS may relate to primary neoplasm
    • Relates to type of paraneoplastic syndrome - Slow, long-term cognitive decline (LE) - Progressive ataxia, weakness (PCD, spinal cord degeneration)
    • Some reports suggest patients with PSs have more indolent primary tumor growth than those without
  • Treatment

    • AE often treated with immunotherapy (IV steroids, plasma exchange, IVIg) ± rituximab or cyclophosphamide
    • Treatment of primary malignancy may improve neurologic symptoms of PS
    • Primary neoplasm resected, ± chemoradiation
    • Treatment of PS is variable - Treatment of primary tumor is best therapy - ± steroids, immunoglobulins, plasmapheresis

DIAGNOSTIC CHECKLIST

  • Consider

    • LE is only PS with defined imaging features
    • PS are often clinically evident before diagnosis of primary tumor
    • Repeat MR if initial scan normal and high clinical suspicion, as initial MR often normal in LE
  • Image Interpretation Pearls

    • Herpes encephalitis mimics LE on imaging but has acute presentation - Patients often initially treated with antiviral therapy until HSV titers final
    • Hemorrhage suggests herpes rather than LE

89d11c00-03ef-4d5a-aea9-2d9c2669fa58

References

Selected References

  1. Iorio R et al: Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic etiology. Eur J Neurol. ePub, 2020
  2. Mongay-Ochoa N et al: Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment. J Neurol. ePub, 2020
  3. Vogrig A et al: Central nervous system complications associated with immune checkpoint inhibitors. J Neurol Neurosurg Psychiatry. ePub, 2020
  4. Bradshaw MJ et al: An overview of autoimmune and paraneoplastic encephalitides. Semin Neurol. 38(3):330-43, 2018
  5. Long JM et al: Autoimmune dementia. Semin Neurol. 38(3):303-15, 2018
  6. Kelley BP et al: Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. AJNR Am J Neuroradiol. 38(6):1070-8, 2017
  7. da Rocha AJ et al: Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders. AJNR Am J Neuroradiol. 36(12):2196-205, 2015
  8. Höftberger R et al: Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology. 84(24):2403-12, 2015
  9. Thomas AC et al: Autoimmune limbic encephalitis detected on FDG brain scan performed for the evaluation of dementia. Clin Nucl Med. 40(4):358-9, 2015
  10. Zekeridou A et al: Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis. J Neurol. 262(8):1859-66, 2015
  11. Kotsenas AL et al: MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol. 35(1):84-9, 2014
  12. Masangkay N et al: Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. Nucl Med Commun. 35(10):1038-46, 2014
  13. Sarria-Estrada S et al: Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis. Clin Radiol. 69(8):795-803, 2014
  14. Baumgartner A et al: Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 260(11):2744-53, 2013
  15. Aye MM et al: CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration. J Neuroimmunol. 208(1-2):136-40, 2009
  16. Berger JR et al: A brainstem paraneoplastic syndrome associated with prostate cancer. J Neurol Neurosurg Psychiatry. 80(8):934-5, 2009
  17. Damek DM: Cerebral edema, altered mental status, seizures, acute stroke, leptomeningeal metastases, and paraneoplastic syndrome. Emerg Med Clin North Am. 27(2):209-29, 2009
  18. Honnorat J et al: Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry. 80(4):412-6, 2009
  19. Jaster JH: Reversible autoimmune encephalopathy spectrum. Arch Neurol. 66(7):916, 2009
  20. Khan NL et al: Histopathology of VGKC antibody-associated limbic encephalitis. Neurology. 72(19):1703-5, 2009
  21. Kröll-Seger J et al: Non-paraneoplastic limbic encephalitis associated with antibodies to potassium channels leading to bilateral hippocampal sclerosis in a pre-pubertal girl. Epileptic Disord. 11(1):54-9, 2009
  22. McKeon A et al: Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images. Arch Neurol. 66(2):268-71, 2009
  23. Modoni A et al: Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies. Cogn Behav Neurol. 22(1):63-6, 2009
  24. Saiz A et al: Anti-Hu-associated brainstem encephalitis. J Neurol Neurosurg Psychiatry. 80(4):404-7, 2009
  25. Uribe-Uribe NO et al: Paraneoplastic sensory neuropathy associated with small cell carcinoma of the gallbladder. Ann Diagn Pathol. 13(2):124-6, 2009
  26. Anderson NE et al: Limbic encephalitis - a review. J Clin Neurosci. 15(9):961-71, 2008
  27. Basu S et al: Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 10(3):131-7, 2008
  28. Blaes F et al: Autoantibodies in childhood opsoclonus-myoclonus syndrome. J Neuroimmunol. 201-202:221-6, 2008
  29. Corapcioglu F et al: Response to rituximab and prednisolone for opsoclonus-myoclonus-ataxia syndrome in a child with ganglioneuroblastoma. Pediatr Hematol Oncol. 25(8):756-61, 2008
  30. Dalakas MC: Invited article: inhibition of B cell functions: implications for neurology. Neurology. 70(23):2252-60, 2008
  31. Eker A et al: Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry. 79(9):1082-3, 2008
  32. Fitzpatrick AS et al: Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma. Neurology. 70(15):1292-3, 2008
  33. Geschwind MD et al: Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol. 65(10):1341-6, 2008
  34. Hassan KA et al: Long-term survival in paraneoplastic opsoclonus-myoclonus syndrome associated with small cell lung cancer. J Neuroophthalmol. 28(1):27-30, 2008
  35. Jarius S et al: Relative frequency of VGKC and 'classical' paraneoplastic antibodies in patients with limbic encephalitis. J Neurol. 255(7):1100-1, 2008
  36. Johnson V et al: Immune mediated neurologic dysfunction as a paraneoplastic syndrome in renal cell carcinoma. J Neurooncol. 90(3):279-81, 2008
  37. Ko MW et al: Neuro-ophthalmologic manifestations of paraneoplastic syndromes. J Neuroophthalmol. 28(1):58-68, 2008
  38. Musunuru K et al: Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma. J Neurooncol. 90(2):213-6, 2008
  39. Novillo-López ME et al: Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology. 70(9):728-9, 2008
  40. Pellkofer HL et al: Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel. J Neuroimmunol. 204(1-2):136-9, 2008
  41. Sabater L et al: SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology. 70(12):924-8, 2008
  42. Sekiguchi Y et al: Potassium channel antibody-associated encephalitis with hypothalamic lesions and intestinal pseudo-obstruction. J Neurol Sci. 269(1-2):176-9, 2008
  43. Tan KM et al: Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 70(20):1883-90, 2008
  44. Darnell RB et al: Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 33(3):270-98, 2006
  45. Dropcho EJ: Update on paraneoplastic syndromes. Curr Opin Neurol. 18(3):331-6, 2005
  46. Dadparvar S et al: Paraneoplastic encephalitis associated with cystic teratoma is detected by fluorodeoxyglucose positron emission tomography with negative magnetic resonance image findings. Clin Nucl Med. 28(11):893-6, 2003
  47. Messori A et al: Resolution of limbic encephalitis with detection and treatment of lung cancer: clinical-radiological correlation. Eur J Radiol. 45(1): 78-80, 2003
  48. Barnett M et al: Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody. J Neurol Neurosurg Psychiatry. 70(2):222-5, 2001
  49. Gultekin SH et al: Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 123 ( Pt 7):1481-94, 2000
  50. Dalmau J et al: Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol. 9(2):275-84, 1999
  51. Scaravilli F et al: The neuropathology of paraneoplastic syndromes. Brain Pathol. 9(2):251-60, 1999
  52. Voltz R et al: A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med. 340(23): 1788-95, 1999

Images

Selected Images

Axial FLAIR MR shows abnormal hyperintensity in the bilateral medial temporal lobes , characteristic of limbic encephalitis (LE), the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis. Axial FLAIR MR shows abnormal hyperintensity in the bilateral medial temporal lobes , characteristic of limbic encephalitis (LE), the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis.

Axial FLAIR MR shows abnormal hyperintensity in the bilateral medial temporal lobes , characteristic of limbic encephalitis (LE), the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis. Axial FLAIR MR shows abnormal hyperintensity in the bilateral medial temporal lobes , characteristic of limbic encephalitis (LE), the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis.

Axial FLAIR MR shows abnormal hyperintensity in the bilateral medial temporal lobes , characteristic of limbic encephalitis (LE), the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis. Axial FLAIR MR shows abnormal hyperintensity in the bilateral medial temporal lobes , characteristic of limbic encephalitis (LE), the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis.

Axial T1 C+ MR in the same patient shows no significant enhancement in the medial temporal lobes. Enhancement is often present in limbic encephalitis. The patient's symptoms often improve after treatment of the primary tumor. Axial T1 C+ MR in the same patient shows no significant enhancement in the medial temporal lobes. Enhancement is often present in limbic encephalitis. The patient's symptoms often improve after treatment of the primary tumor.

Axial T1 C+ MR in the same patient shows no significant enhancement in the medial temporal lobes. Enhancement is often present in limbic encephalitis. The patient's symptoms often improve after treatment of the primary tumor. Axial T1 C+ MR in the same patient shows no significant enhancement in the medial temporal lobes. Enhancement is often present in limbic encephalitis. The patient's symptoms often improve after treatment of the primary tumor.

Axial FLAIR MR in a 61 year old with multiple myeloma who presented with seizures shows abnormal hyperintensity  in the cortex and subcortical white matter of the temporal lobes. Axial FLAIR MR in a 61 year old with multiple myeloma who presented with seizures shows abnormal hyperintensity in the cortex and subcortical white matter of the temporal lobes.

Axial FLAIR MR in a 61 year old with multiple myeloma who presented with seizures shows abnormal hyperintensity  in the cortex and subcortical white matter of the temporal lobes. Axial FLAIR MR in a 61 year old with multiple myeloma who presented with seizures shows abnormal hyperintensity in the cortex and subcortical white matter of the temporal lobes.

Axial T1 C+ FS MR in the same patient shows no enhancement. Differential considerations include autoimmune encephalitis (AE), acute demyelinating encephalomyelitis (ADEM), viral encephalitis, and vasculitis in this case. AE related to GABAr was diagnosed by CSF and serum markers. Axial T1 C+ FS MR in the same patient shows no enhancement. Differential considerations include autoimmune encephalitis (AE), acute demyelinating encephalomyelitis (ADEM), viral encephalitis, and vasculitis in this case. AE related to GABAr was diagnosed by CSF and serum markers.

Axial T1 C+ FS MR in the same patient shows no enhancement. Differential considerations include autoimmune encephalitis (AE), acute demyelinating encephalomyelitis (ADEM), viral encephalitis, and vasculitis in this case. AE related to GABAr was diagnosed by CSF and serum markers. Axial T1 C+ FS MR in the same patient shows no enhancement. Differential considerations include autoimmune encephalitis (AE), acute demyelinating encephalomyelitis (ADEM), viral encephalitis, and vasculitis in this case. AE related to GABAr was diagnosed by CSF and serum markers.

Axial FLAIR MR in a 71 year old with altered mental status shows abnormal hyperintensity in the left temporal lobe  . Differential considerations include infectious, inflammatory, and neoplastic etiologies. GAD65 AE was diagnosed at brain biopsy. Axial FLAIR MR in a 71 year old with altered mental status shows abnormal hyperintensity in the left temporal lobe . Differential considerations include infectious, inflammatory, and neoplastic etiologies. GAD65 AE was diagnosed at brain biopsy.

Axial FLAIR MR in a 71 year old with altered mental status shows abnormal hyperintensity in the left temporal lobe  . Differential considerations include infectious, inflammatory, and neoplastic etiologies. GAD65 AE was diagnosed at brain biopsy. Axial FLAIR MR in a 71 year old with altered mental status shows abnormal hyperintensity in the left temporal lobe . Differential considerations include infectious, inflammatory, and neoplastic etiologies. GAD65 AE was diagnosed at brain biopsy.

Axial FLAIR MR shows hyperintensity in the medial temporal lobes  in this patient with subacute dementia and voltage-gated potassium channel (VGKC) autoimmunity. VGKC may occur with or without a primary neoplasm and may have an LE pattern. Axial FLAIR MR shows hyperintensity in the medial temporal lobes in this patient with subacute dementia and voltage-gated potassium channel (VGKC) autoimmunity. VGKC may occur with or without a primary neoplasm and may have an LE pattern.

Axial FLAIR MR shows hyperintensity in the medial temporal lobes  in this patient with subacute dementia and voltage-gated potassium channel (VGKC) autoimmunity. VGKC may occur with or without a primary neoplasm and may have an LE pattern. Axial FLAIR MR shows hyperintensity in the medial temporal lobes in this patient with subacute dementia and voltage-gated potassium channel (VGKC) autoimmunity. VGKC may occur with or without a primary neoplasm and may have an LE pattern.

Axial T2 MR shows midbrain hyperintensity  related to brainstem encephalitis, which is characterized by hyperintensity in the midbrain, pons, cerebellar peduncle, and basal ganglia. Axial T2 MR shows midbrain hyperintensity related to brainstem encephalitis, which is characterized by hyperintensity in the midbrain, pons, cerebellar peduncle, and basal ganglia.

Axial T2 MR shows midbrain hyperintensity  related to brainstem encephalitis, which is characterized by hyperintensity in the midbrain, pons, cerebellar peduncle, and basal ganglia. Axial T2 MR shows midbrain hyperintensity related to brainstem encephalitis, which is characterized by hyperintensity in the midbrain, pons, cerebellar peduncle, and basal ganglia.

Axial T1 C+ MR in the same patient shows patchy enhancement of the midbrain lesions  and the medial temporal lobe . This patient was diagnosed with LE with new brainstem symptoms. Multiple paraneoplastic syndromes may occur in the same patient. Axial T1 C+ MR in the same patient shows patchy enhancement of the midbrain lesions and the medial temporal lobe . This patient was diagnosed with LE with new brainstem symptoms. Multiple paraneoplastic syndromes may occur in the same patient.

Axial T1 C+ MR in the same patient shows patchy enhancement of the midbrain lesions  and the medial temporal lobe . This patient was diagnosed with LE with new brainstem symptoms. Multiple paraneoplastic syndromes may occur in the same patient. Axial T1 C+ MR in the same patient shows patchy enhancement of the midbrain lesions and the medial temporal lobe . This patient was diagnosed with LE with new brainstem symptoms. Multiple paraneoplastic syndromes may occur in the same patient.

Axial FLAIR MR shows abnormal hyperintensity in the medial temporal lobes bilaterally, related to LE. As imaging mimics herpes encephalitis, most patients are initially treated with antiviral therapy until HSV titers are found to be negative. < 1% of cancer patients develop a paraneoplastic syndrome. Axial FLAIR MR shows abnormal hyperintensity in the medial temporal lobes bilaterally, related to LE. As imaging mimics herpes encephalitis, most patients are initially treated with antiviral therapy until HSV titers are found to be negative. < 1% of cancer patients develop a paraneoplastic syndrome.

Axial FLAIR MR shows abnormal hyperintensity in the medial temporal lobes bilaterally, related to LE. As imaging mimics herpes encephalitis, most patients are initially treated with antiviral therapy until HSV titers are found to be negative. < 1% of cancer patients develop a paraneoplastic syndrome. Axial FLAIR MR shows abnormal hyperintensity in the medial temporal lobes bilaterally, related to LE. As imaging mimics herpes encephalitis, most patients are initially treated with antiviral therapy until HSV titers are found to be negative. < 1% of cancer patients develop a paraneoplastic syndrome.

Axial T1 C+ MR in the same patient shows patchy enhancement  of the medial temporal lobes. LE is the only paraneoplastic syndrome with defined imaging features. Axial T1 C+ MR in the same patient shows patchy enhancement of the medial temporal lobes. LE is the only paraneoplastic syndrome with defined imaging features.

Additional Images

Axial T2 MR shows abnormal hyperintensity in the right medial temporal lobe , typical of limbic encephalitis. Note the abnormal hyperintensity in the midbrain , indicative of brainstem encephalitis. Brainstem encephalitis is a very uncommon paraneoplastic syndrome. Multiple paraneoplastic syndromes can occur in the same patient. Axial T2 MR shows abnormal hyperintensity in the right medial temporal lobe , typical of limbic encephalitis. Note the abnormal hyperintensity in the midbrain , indicative of brainstem encephalitis. Brainstem encephalitis is a very uncommon paraneoplastic syndrome. Multiple paraneoplastic syndromes can occur in the same patient.

Axial FLAIR MR in a patient with subacute dementia and lung cancer shows hyperintensity within the medial temporal lobes, classic for limbic encephalitis. Imaging mimics herpes encephalitis. Axial FLAIR MR in a patient with subacute dementia and lung cancer shows hyperintensity within the medial temporal lobes, classic for limbic encephalitis. Imaging mimics herpes encephalitis.

Axial T1 C+ MR shows subtle patchy enhancement of the medial temporal lobes bilaterally , which is a typical enhancement pattern for limbic encephalitis. Bilateral involvement is common. Axial T1 C+ MR shows subtle patchy enhancement of the medial temporal lobes bilaterally , which is a typical enhancement pattern for limbic encephalitis. Bilateral involvement is common.

Coronal T2 MR in a patient with limbic encephalitis shows abnormal hyperintensity in the medial temporal lobes and right insula  in this patient with severe memory loss and dementia. Symptoms improved after the removal of the primary tumor. Coronal T2 MR in a patient with limbic encephalitis shows abnormal hyperintensity in the medial temporal lobes and right insula in this patient with severe memory loss and dementia. Symptoms improved after the removal of the primary tumor.

Coronal T1 C+ MR shows abnormal gyriform enhancement in the medial temporal lobes and left insula . The more typical patchy enhancement pattern of limbic encephalitis is seen in the hippocampi bilaterally. Coronal T1 C+ MR shows abnormal gyriform enhancement in the medial temporal lobes and left insula . The more typical patchy enhancement pattern of limbic encephalitis is seen in the hippocampi bilaterally.

Axial T1 MR shows hyperintensity representing blood products in the medial temporal lobes in this patient with treated lung cancer and limbic encephalitis. Blood products are rare in limbic encephalitis, in which imaging mimics herpes encephalitis. Axial T1 MR shows hyperintensity representing blood products in the medial temporal lobes in this patient with treated lung cancer and limbic encephalitis. Blood products are rare in limbic encephalitis, in which imaging mimics herpes encephalitis.

Axial FLAIR MR shows abnormal hyperintensity in the right medial temporal lobe and midbrain in this patient with a history of limbic encephalitis and new brainstem symptoms positive for anti-Hu autoantibody. Axial FLAIR MR shows abnormal hyperintensity in the right medial temporal lobe and midbrain in this patient with a history of limbic encephalitis and new brainstem symptoms positive for anti-Hu autoantibody.

Axial T1 C+ MR shows enhancement in the medial temporal lobes and left anterior temporal lobe related to limbic encephalitis. As imaging mimics herpes encephalitis, most patients are initially treated with antiviral therapy until HSV titers are found to be negative. Axial T1 C+ MR shows enhancement in the medial temporal lobes and left anterior temporal lobe related to limbic encephalitis. As imaging mimics herpes encephalitis, most patients are initially treated with antiviral therapy until HSV titers are found to be negative.

Axial FLAIR MR shows abnormal hyperintensity in the medial temporal lobes bilaterally, characteristic of limbic encephalitis, the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis. Axial FLAIR MR shows abnormal hyperintensity in the medial temporal lobes bilaterally, characteristic of limbic encephalitis, the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis.

Axial FLAIR MR in an older adult with small cell lung cancer and subacute dementia shows striking hyperintensity in the right insula . Axial FLAIR MR in an older adult with small cell lung cancer and subacute dementia shows striking hyperintensity in the right insula .

Coronal T2 MR in the same patient shows abnormal hyperintensity in both medial temporal lobes  and right insular cortex . Imaging of limbic encephalitis mimics that of herpes encephalitis; however, patients with limbic encephalitis have a subacute presentation. Hemorrhage suggests herpes rather than limbic encephalitis. Coronal T2 MR in the same patient shows abnormal hyperintensity in both medial temporal lobes and right insular cortex . Imaging of limbic encephalitis mimics that of herpes encephalitis; however, patients with limbic encephalitis have a subacute presentation. Hemorrhage suggests herpes rather than limbic encephalitis.

Axial FLAIR MR shows abnormal hyperintensity in the medial temporal lobes bilaterally, characteristic of limbic encephalitis, the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis. Axial FLAIR MR shows abnormal hyperintensity in the medial temporal lobes bilaterally, characteristic of limbic encephalitis, the most common paraneoplastic syndrome. Bilateral involvement is typical of limbic encephalitis.